Late on Tuesday, Starbucks rolled out some long-term strategic initiatives to regain momentum on both the top and bottom line. The Seattle-based company stated that it plans to shut more unprofitable stores in big US cities in the fiscal year 2019 and will slow the pace at which it opens new stores. Starbucks also provided weak sales outlook. The news sent Starbucks shares plunging 4.54% during the after-hours trading.
The coffee store chain, which has over 8,000 stores nationwide, told investors that it plans to shutter 150 stores in the next fiscal year, highlighting a three-fold increase in the number of stores it plans to close. Annually, Starbucks shuts no more than 50 underperforming stores. The company, however, plans to open new stores in other regions, but the overall rate at which it opens those stores will be slow.
The Seattle-based company stated that it plans to shut more unprofitable stores in big US cities in the fiscal year 2019 and will slow the pace at which it opens new stores.
For the upcoming quarter, Starbucks provided weaker-than-expected sales outlook. The company expects just 1% rise in its same-store sales, much below the analysts’ estimate of 3%.
The strategic plans — which includes accelerating growth in China and US, focusing on shareholder return, as well as expanding the global reach of the company — are expected to boost the company’s returns. The company now plans to return approx. $25 billion in cash to its shareholders either through share buybacks or dividends through 2022. Starbucks declared a 20% hike to its dividend to a quarterly return of $0.36 a share.
“While certain demand headwinds are transitory, and some of our cost increases are appropriate investments for the future, our recent performance does not reflect the potential of our exceptional brand and is not acceptable,” said CEO Kevin Johnson in a statement.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on